Detailed answers about DWIB (DANIEL WHYTE & IVOR BURFORD) LEUKAEMIA TRUST (UK), including incorporation, status, business activity, and accounts information.
When was DWIB (DANIEL WHYTE & IVOR BURFORD) LEUKAEMIA TRUST (UK) founded?
DWIB (DANIEL WHYTE & IVOR BURFORD) LEUKAEMIA TRUST (UK) was officially incorporated on 21 July 2006 and is registered under company number 05883298. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DWIB (DANIEL WHYTE & IVOR BURFORD) LEUKAEMIA TRUST (UK)?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of DWIB (DANIEL WHYTE & IVOR BURFORD) LEUKAEMIA TRUST (UK)?
DWIB (DANIEL WHYTE & IVOR BURFORD) LEUKAEMIA TRUST (UK)'s current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DWIB (DANIEL WHYTE & IVOR BURFORD) LEUKAEMIA TRUST (UK) do?
DWIB (DANIEL WHYTE & IVOR BURFORD) LEUKAEMIA TRUST (UK) operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is DWIB (DANIEL WHYTE & IVOR BURFORD) LEUKAEMIA TRUST (UK)'s registered address?
The registered office address of DWIB (DANIEL WHYTE & IVOR BURFORD) LEUKAEMIA TRUST (UK) is 32 PAKINGTON HOUSE, CROSSFORD STREET, LONDON, SW9 9BA. This is the official address filed with Companies House for legal and statutory correspondence.
The most recent accounts for DWIB (DANIEL WHYTE & IVOR BURFORD) LEUKAEMIA TRUST (UK) were made up to 31 July 2024, filed as MICRO ENTITY. Next accounts are due by 30 April 2026.